Evidence map›Paper›PMID 41226921›Full record

ArticleJournal of clinical medicine2025

Diagnostic Performance of Second-Generation Fujifilm SILVAMP TB LAM in Nigerian Adults with Presumptive Tuberculosis.

Nadiia Tytarenko, John S Bimba, Didac Vulcano, Patricia Comella-Del-Barrio, Okoedoh Osazuwa, Jacob Creswell, José Domínguez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nadiia TytarenkoInstitut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias (CIBERES), Universitat Autònoma de Barcelona, Carretera del Canyet, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
John S BimbaZankli Research Centre and Department of Community Medicine, Bingham University, Karu 961105, Nigeria.ORCID 0000-0001-7847-4271
Didac VulcanoInstitut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias (CIBERES), Universitat Autònoma de Barcelona, Carretera del Canyet, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Patricia Comella-Del-BarrioInstitut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias (CIBERES), Universitat Autònoma de Barcelona, Carretera del Canyet, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.ORCID 0000-0002-2433-9864
Okoedoh OsazuwaZankli Research Centre and Department of Community Medicine, Bingham University, Karu 961105, Nigeria.
Jacob CreswellInnovations & Grants, Stop TB Partnership, 1218 Geneva, Switzerland.ORCID 0000-0002-4885-940X
José DomínguezInstitut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias (CIBERES), Universitat Autònoma de Barcelona, Carretera del Canyet, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.

Funding

European and Developing Countries Clinical Trial Partnership EDCTP, DRIA2014-309Instituto de Salud Carlos III PI22/01834The Stop TB Partnership TB REACH CA-3-D000920001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIVLAMlipoarabinomannantuberculosisurine

Identifiers

PMID41226921
PMCPMC12608223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.